Duresin Oral Dispersible Film 0.2mg (Desmopressin Acetate)

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only): Administer 0.1mg of desmopressin acetate orally at bedtime. If the effect is insufficient after 1 week, increase the dose to 0.2mg. If the effect remains insufficient, the dose may be increased at 1-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after dose titration. Immediately after removing this medicine from its individual package, place it on the tongue, allow it to dissolve, and take it without water. This medicine is an orally disintegrating tablet. Once it has dissolved, do not keep it in the mouth; swallow it immediately.

Child dose

Primary nocturnal enuresis (age 5 years and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased to 0.4mg. Whether to continue treatment should be determined after 3 months of administration, with treatment withheld for at least 1 week.

This medication helps regulate the body's water balance. When taking this medication, it is important to avoid excessive fluid intake, especially to drink only as much water as necessary when feeling thirsty. There is a risk of developing hyponatremia (low sodium level in the blood) and water intoxication, which could lead to a coma. This medication should not be administered to patients with certain conditions, such as renal failure, heart failure, and habitual diabetes insipidus. Caution should be exercised for individuals with hypertension, chronic kidney disease, pregnant women, and the elderly; they may require close observation by a physician during treatment. This medication may cause side effects including headache, nausea, skin allergic reactions, weight gain, and seizures, so it is important to consult with a healthcare professional immediately if symptoms occur. During treatment, fluid intake should be restricted, particularly adjusting water intake for a certain period before and after administration. Regular monitoring of sodium levels in the blood is necessary to manage the risk of hyponatremia. When taking other medications, interactions may occur, so all medications being taken should be reported to the healthcare professional. Pregnant or breastfeeding women should carefully consider the potential effects on the fetus or baby before taking this medication. In case of overdose, symptoms such as headache, nausea, seizures, loss of consciousness may appear, and immediate medical attention should be sought. It is very important to precisely follow the instructions of the healthcare professional and adhere to the prescribed dosage and administration guidelines.

• coma
• convulsions
• weight gain
• severe water intoxication
• hyponatremia
• allergic reactions
• emotional disturbances
• headache
• abdominal pain
• nausea

This medication should be kept in a tightly sealed container to avoid exposure to air or moisture; it is recommended to store it at room temperature between 1°C to 30°C. Storing it this way helps maintain the medication's effectiveness.

Appearance

Pink or light pink rectangular oral dispersible film

Package unit

15 pieces (1 piece/Aluminum foil packaging X15)